MAP2K7 and melanoma: The MAPK pathway could provide such signalling (Gray‐Schopfer et al., 2007), and indeed, long‐term BRAF or MEK inhibitor treatment of melanoma cells can trigger melanogenesis (Haq et al., 2013a).